The general pooled evaluation showed a statistically substantial percent reduction in body weight of the retatrutide group when contrasted to the placebo group after 36 weeks of treatment, with an overall MD of − 14.33 (95% CI: − 18.27 to − 10.39, P retatrutide peptide 20 Mg</a> disclosed that individuals might lose approximately a quarter of their body weight in under a year, making it almost two times as effective as Ozempic.